<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00002431</url>
  </required_header>
  <id_info>
    <org_study_id>050A</org_study_id>
    <secondary_id>CC-220</secondary_id>
    <nct_id>NCT00002431</nct_id>
  </id_info>
  <brief_title>The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients</brief_title>
  <official_title>A Multi-Center Trial to Evaluate the Safety and Effectiveness of Peridex Dosed Twice or Three Times Daily for Preventing or Delaying the Occurrence of Lesions Due to Oral Candidiasis in HIV-Positive Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Procter and Gamble</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NIH AIDS Clinical Trials Information Service</source>
  <brief_summary>
    <textblock>
      To evaluate the safety and effectiveness of Peridex (an oral rinse containing chlorhexidine
      gluconate) for preventing the occurrence of clinically-evident microbiologically-documented
      oral candidiasis in HIV-positive patients, who are at risk of the disease based on previous
      history of candidiasis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <condition>Candidiasis, Oral</condition>
  <condition>HIV Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine gluconate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        Prior Medication:

        Allowed within 6 months of study entry:

          -  Treatment for oral candidiasis.

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following conditions or symptoms are excluded:

          -  Either history of esophageal candidiasis or current mucocutaneous candidiasis (angular
             cheilitis).

          -  Allergies to chlorhexidine.

          -  Gross periodontal neglect or need for periodontal treatment within the past two weeks.

        Concurrent Medication:

        Excluded:

          -  Systemic or oral topical mucocutaneous antifungal therapy.

          -  Systemic or oral topical corticosteroids.

          -  Antibiotics.

          -  Mouth rinses other than the study drug.

        Concurrent Treatment:

        Excluded:

          -  Dental prophylaxis.

        Patients with the following are excluded:

          -  Complete dentures, full partial dentures, removable dentures which fit poorly, or any
             prosthetic appliances which cannot be cleaned with sodium hypochlorite.

          -  Allergies to chlorhexidine.

          -  Sensitivity/intolerance to alcohol.

          -  Anterior composite/acrylic restorations with poor marginal adaption.

          -  Gross periodontal neglect or periodontal treatment within the past two weeks.

          -  Inability to comply with the study protocol based on the investigator's discretion.

        Prior Medication:

        Excluded within 7 days of study entry:

          -  Systemic or oral topical mucocutaneous antifungal therapy.

          -  Antibiotics.

          -  Daily use of mouth rinses.

          -  Excluded within 1 month of study entry:

          -  Systemic or oral topical corticosteroids.

        Prior Treatment:

        Excluded within 2 weeks of starting study drug:

          -  Dental prophylaxis or periodontal treatment.

        Patients must be:

          -  HIV positive.

          -  Previously experienced at least one episode of clinically diagnosed oral candidiasis
             but currently free of clinical signs of oral candidiasis.

          -  Willing to sign informed consent.

          -  Willing to complete a medical history.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dental Research Institute / UCLA Med Ctr</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>900951762</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF / Stomatology Clinical Ctr</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State Univ Hosp Clinic</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>432101228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bering Dental Clinic</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hermann Hosp / Univ Texas Health Science Ctr</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Greenspan D. Treatment of oral candidiasis in HIV infection. Oral Surg Oral Med Oral Pathol. 1994 Aug;78(2):211-5. Review.</citation>
    <PMID>7936591</PMID>
  </reference>
  <verification_date>November 1993</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 1999</study_first_submitted>
  <study_first_submitted_qc>August 30, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2001</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>AIDS-Related Opportunistic Infections</keyword>
  <keyword>chlorhexidine gluconate</keyword>
  <keyword>Acquired Immunodeficiency Syndrome</keyword>
  <keyword>Anti-Infective Agents, Local</keyword>
  <keyword>AIDS-Related Complex</keyword>
  <keyword>Candidiasis, Oral</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Candidiasis</mesh_term>
    <mesh_term>Candidiasis, Oral</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

